HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness

Clinical trial NCT07369622 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07369622
Sponsor: Haiphong University of Medicine and Pharmacy
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Gout Initiating Urate-loweringUrate-lowering Therapy Gout Arthritis Gout and Hyperuricemia

Start date: 2026-01-20
Primary completion: 2027-06-20
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.